The short answer
Aspartimide formation is a sequence-dependent side reaction in solid-phase synthesis of peptides containing aspartate. The backbone amide attacks the aspartate side chain to form a five-membered ring, which then opens to give products including isoaspartyl peptides of identical mass.
Key facts
- Affects
- Peptides containing aspartate
- Sequence-dependent
- Yes, Asp-Ala is a documented motif
- Catalysed by
- Acid or base
- Mechanism
- Adjacent amide attacks the side chain
- Ring formed
- Five-membered succinimide
- Key product
- Isoaspartyl peptide (same mass)
- Also occurs in
- Formulations, not only synthesis
What actually happens
The nitrogen of the peptide bond immediately following an aspartate residue attacks the carbonyl of that aspartate's side chain. That closes a five-membered ring: the aspartimide, a succinimide. Ruczyński and colleagues described it in the Journal of Peptide Science in 2008 as one of the most serious side reactions in solid-phase synthesis of aspartate-containing peptides, and both acid and base catalyse it.
Why the ring reopening is the real problem
The aspartimide is unstable and opens again, but it can open two ways. One restores the original aspartate linkage. The other produces an isoaspartyl peptide, where the chain now runs through the side-chain carboxyl instead of the backbone one: the same atoms in a different connectivity. Cao and colleagues reported in Biochemistry in 2023 that hydrolysis proceeds regioselectively above pH 7, so conditions determine which way it resolves.
Research material referenced
BPC-157 5mg, third-party HPLC tested
Why mass spectrometry cannot see it
An isoaspartyl peptide has the identical molecular formula and therefore the identical mass. Nothing was added and nothing was lost; a bond simply moved. A mass spectrum of a preparation substantially converted to isoaspartate looks exactly like a mass spectrum of the intended compound, which is why this impurity survives the check most certificates lead with.
Why it is sequence-dependent
The reaction needs the adjacent backbone nitrogen to reach the side-chain carbonyl, so what follows the aspartate governs how readily it happens. Small, unhindered residues make the approach easy. Ruczyński's work modelled the Asp-Ala motif specifically for this reason, and susceptibility varies substantially with the neighbouring residue.
Which compounds in this catalogue carry the motif
Both aspartate-containing peptides here. BPC-157 is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, which places an Asp-Ala pairing in the middle of the sequence. DSIP is Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, with the same Asp-Ala pairing. Neither is an unusual sequence, and neither product listing mentions the susceptibility.
That it is not only a synthesis problem
Cao and colleagues describe aspartimides as undesired side products in solid-phase synthesis and in pharmaceutical formulations. The chemistry does not stop when synthesis finishes. It can proceed slowly in a stored preparation, which makes it a stability consideration as well as a manufacturing one, and it is pH-sensitive in both settings.
Frequently asked questions
What is aspartimide formation?
A side reaction where the backbone amide following an aspartate attacks its side chain, forming a five-membered succinimide ring that can reopen incorrectly.
Why can't mass spectrometry detect the impurity?
The isoaspartyl product has the identical formula and mass. A bond moved; nothing was added or lost.
Which sequences are most at risk?
It is sequence-dependent, with small unhindered residues after the aspartate favouring it. Asp-Ala is a documented susceptible motif.
Continue researching
Related guides and reference material.
Primary sources & clinical trials
Published papers, trial registrations, regulator pages and company announcements. Links open the original.
- PubMedRuczyński J et al., Problem of aspartimide formation in Fmoc-based solid-phase peptide synthesis. J Pept Sci 2008 (PMID 17975850)pubmed.ncbi.nlm.nih.gov
- PubMedCao L et al., Kinetics of Aspartimide Formation and Hydrolysis in Lasso Peptide Lihuanodin. Biochemistry 2023 (PMID 36701287)pubmed.ncbi.nlm.nih.gov
- PubMedJaradat DMM, Thirteen decades of peptide synthesis. Amino Acids 2018 (PMID 29185032)pubmed.ncbi.nlm.nih.gov
Browse the wider literature
Live database searches, not fixed citations. Results change as new work is indexed.
Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).
Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.
More Peptide Reference articles
- What a Clean Mass Spectrum Does Not ProveIsoaspartyl peptides, D-amino acid epimers and misfolded disulfide isomers all weigh exactly the same as the target. Mass cannot distinguish any of them.
- Endotoxin: The Contaminant That Is Not a ProteinEndotoxin provokes strong biological responses at tiny concentrations and appears in no purity figure. It can also hide from the assay meant to find it.
- Peptides and Muscle Growth: Claims Against EvidenceThe compounds marketed for muscle growth work by different mechanisms, and most evidence measures hormones rather than muscle. What has actually been shown.
- Are Peptides Safe? It Depends Entirely on Which OneInsulin is a peptide. So is a compound with no human data at all. Safety is a property of the specific molecule and the specific material, not of the category.
- Are Peptides Steroids?No. Peptides are amino acid chains; steroids are built on a four-ring carbon skeleton. Different structures, different receptors, different regulation.